181
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Expression of the Multidrug-Resistance Gene Product in Untreated Human Breast Cancer and its Relationship to Prognostic Markers

, , , &
Pages 773-777 | Received 09 Dec 1993, Accepted 11 May 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

João Marcos de Azevedo Delou, Giselle Maria Vignal, Vanessa Índio-do-Brasil, Maria Theresa de Souza Accioly, Taiana Sousa Lopes da Silva, Diogo Nascimento Piranda, Marcelo Sobral-Leite, Marcelo Alex de Carvalho, Márcia Alves Marques Capella & Rosane Vianna-Jorge. (2017) Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis. Breast Cancer: Targets and Therapy 9, pages 415-428.
Read now

Articles from other publishers (6)

Devchand Paul & Kenneth H. Cowan. 1999. Breast Cancer. Breast Cancer 481 517 .
S. Hegewisch-Becker, F. Staib, T. Löning, U. Pichlmeier, N. Kröger, A. Reymann & D.K. Hossfeld. (1998) No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer. Annals of Oncology 9:1, pages 85-93.
Crossref
B. J. Trock, F. Leonessa & R. Clarke. (1997) Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance. JNCI Journal of the National Cancer Institute 89:13, pages 917-931.
Crossref
Susan D. Huan, Jonathan C. Yau, Eva Tomiak, Rakesh Goel, Christine Cripps, Stan Z. Gertler, Isobel A. Prosser & David J. Stewart. (2018) Hydroxyurea Did Not Enhance the Clinical Response to Vinblastine in Patients with Anthracycline-Resistant Metastatic Breast Cancer. Tumori Journal 82:6, pages 576-578.
Crossref
Irene Bosch & James Croop. (1996) P-glycoprotein multidrug resistance and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1288:2, pages F37-F54.
Crossref
Lester E. Wold, James N. Ingle, Thomas M. Pisansky, Ruth E. Johnson & John H. Donohue. (1995) Prognostic Factors for Patients With Carcinoma of the Breast. Mayo Clinic Proceedings 70:7, pages 678-679.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.